GSK PLC (GLAXF)
22.03
+0.89
(+4.22%)
USD |
OTCM |
May 07, 15:42
GSK Price: 22.03 for May 7, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 06, 2024 | 21.14 | 21.14 | 21.14 | 21.14 | 0.000 |
May 03, 2024 | 21.14 | 21.14 | 21.14 | 21.14 | 270.00 |
May 02, 2024 | 21.00 | 21.00 | 21.00 | 21.00 | 0.000 |
May 01, 2024 | 20.04 | 21.00 | 20.04 | 21.00 | 2692.00 |
Apr 30, 2024 | 22.14 | 22.14 | 20.04 | 20.80 | 1462.00 |
Apr 29, 2024 | 21.50 | 21.50 | 21.30 | 21.30 | 1120.00 |
Apr 26, 2024 | 19.85 | 19.85 | 19.85 | 19.85 | 0.000 |
Apr 25, 2024 | 19.85 | 19.85 | 19.85 | 19.85 | 0.000 |
Apr 24, 2024 | 19.85 | 19.85 | 19.85 | 19.85 | 165.00 |
Apr 23, 2024 | 19.66 | 19.66 | 19.54 | 19.54 | 2558.00 |
Apr 22, 2024 | 19.30 | 20.30 | 19.30 | 20.30 | 629.00 |
Apr 19, 2024 | 20.20 | 20.20 | 20.20 | 20.20 | 0.000 |
Apr 18, 2024 | 20.20 | 20.20 | 20.20 | 20.20 | 0.000 |
Apr 17, 2024 | 20.20 | 20.20 | 20.20 | 20.20 | 0.000 |
Apr 16, 2024 | 20.20 | 20.20 | 20.20 | 20.20 | 0.000 |
Apr 15, 2024 | 19.87 | 20.20 | 19.87 | 20.20 | 512.00 |
Apr 12, 2024 | 20.25 | 20.42 | 20.07 | 20.07 | 1024.00 |
Apr 11, 2024 | 19.83 | 20.50 | 19.83 | 20.50 | 11201.00 |
Apr 10, 2024 | 20.84 | 20.84 | 20.84 | 20.84 | 0.000 |
Apr 09, 2024 | 20.71 | 20.84 | 20.10 | 20.84 | 1532.00 |
Apr 08, 2024 | 20.75 | 20.75 | 20.75 | 20.75 | 0.000 |
Apr 05, 2024 | 20.75 | 20.75 | 20.75 | 20.75 | 333.00 |
Apr 04, 2024 | 20.18 | 20.94 | 20.18 | 20.90 | 1274.00 |
Apr 03, 2024 | 20.78 | 21.45 | 20.78 | 21.08 | 1069.00 |
Apr 02, 2024 | 20.90 | 20.90 | 20.90 | 20.90 | 1764.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.71
Minimum
Sep 22 2022
29.75
Maximum
Jan 21 2020
22.62
Average
23.62
Median
Sep 30 2020
Price Benchmarks
Adaptimmune Therapeutics PLC | 1.10 |
Biodexa Pharmaceuticals Plc | 1.01 |
Verona Pharma PLC | 14.80 |
NuCana PLC | 3.94 |
Autolus Therapeutics PLC | 4.01 |
Price Related Metrics
PE Ratio | 17.27 |
PS Ratio | 2.489 |
Price to Book Value | 5.142 |
Price to Free Cash Flow | 14.61 |
Earnings Yield | 5.79% |
Market Cap | 89.85B |
Operating PE Ratio | 11.32 |
Normalized PE Ratio | 15.64 |